Enovix Corporation

As of June 30, 2026, Enovix Corporation carries a market capitalization of 1.17B, placing it among publicly traded companies globally. Its enterprise value stands at 1.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Enovix Corporation's next confirmed earnings release is scheduled for February 24, 2027.

As of June 30, 2026, Enovix Corporation has 219.20M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 36.64, and the price-to-book ratio stands at 6.39.

These figures are as of June 30, 2026. The EV/Sales ratio of 39.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.23B versus a market cap of 1.17B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Enovix Corporation maintains a current ratio of 9.71, meaning it holds 9.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 253.54, indicating elevated leverage, while an interest coverage ratio of -4.44 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Enovix Corporation posted a negative return on equity (ROE) of -82.20, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -26.80, reflecting losses generated across the asset base. The company generates approximately 49,031.83 in revenue per employee across its workforce of 640.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.88 indicates how many times Enovix Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Enovix Corporation recorded an income tax benefit of -751,882.70 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -149.68M and -148.82M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 6, 2026, Enovix Corporation's stock has declined approximately 77.44% over the past 52 weeks. The 50-day moving average sits at 3.00, while the 200-day moving average is 4.82.

Over the twelve months ended June 30, 2026, Enovix Corporation generated 31.40M in revenue and converted that into -148.82M in net income, yielding earnings per share of -0.69. EBITDA reached -123.34M, while operating income came in at -155.94M.

As of June 30, 2026, Enovix Corporation holds 416.45M in cash and equivalents against 470.46M in total debt, resulting in a net debt position of 435.76M. Total book value stands at 183.76M, with working capital of 397.06M providing operational flexibility.

Enovix Corporation produced -93.99M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -14.73M in capital expenditures, free cash flow totaled -108.71M - equivalent to -0.51 per share.

Over the twelve months ended June 30, 2026, Enovix Corporation posted a gross margin of 18.83, reflecting its pricing power and cost economics. The operating margin of -496.54 and net profit margin of -473.89 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -9.44: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -34.87, meaning Enovix Corporation raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Enovix Corporation has an Altman Z-Score of -0.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.